TILT BIOTHERAPEUTICS OY
EIC Accelerator Winner From 2022
Fighting cancer with next generation oncolytic immunotherapy in ovarian, head & neck, and lung cancers (Immune Checkpoint Response Enabling Adenovirus Technology )
Finland
Articles
EIC Accelerator Funding Powers TILT Biotherapeutics' Cancer Immunotherapy Advancements
FinlandEIC Accelerator2022
Read ArticleEIC Accelerator Empowers TILT Biotherapeutics in Advancing Cancer Immunotherapy Solutions
FinlandEIC Accelerator2024
Read Article